Amedeo Smart

Free Medical Literature Service

 

Amedeo

Neoplasms of the CNS
  Free Subscription

Articles published in
J Nucl Med
    March 2026
  1. GEENS W, Buyck F, Raes L, Schwarze JK, et al
    Prognostic Value of O-(2-(18)F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 26:jnumed.125.270727. doi: 10.2967/jnumed.125.270727.
    >> Share

  2. LI EJ, Kraya A, Costa-Pinheiro P, Scheuermann J, et al
    Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 19:jnumed.125.271476. doi: 10.2967/jnumed.125.271476.
    >> Share

    January 2026
  3. WERNER JM, Lohmann P, Kabbasch C, Wollring MM, et al
    Assessment of Response to Regorafenib in Patients with Glioma Relapse Using (18)F-FET PET and MRI.
    J Nucl Med. 2026 Jan 8:jnumed.125.270946. doi: 10.2967/jnumed.125.270946.
    >> Share

    October 2025
  4. CHEN WC, Raleigh DR
    Rational Radionuclide Therapy for Recurrent Meningioma.
    J Nucl Med. 2025 Oct 16:jnumed.125.270775. doi: 10.2967/jnumed.125.270775.
    >> Share

  5. TOLBOOM N, Albert NL, Braat AJAT, Snijders TJ, et al
    From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials.
    J Nucl Med. 2025 Oct 16:jnumed.125.270820. doi: 10.2967/jnumed.125.270820.
    >> Share

    September 2025
  6. EBNER R, Braach J, Rubenthaler J, Cyran CC, et al
    Retrospective Evaluation of the Correlation Between Somatostatin Receptor PET/CT and Histopathology in Patients with Suspected Intracranial Meningiomas.
    J Nucl Med. 2025 Sep 11:jnumed.125.270115. doi: 10.2967/jnumed.125.270115.
    >> Share

    August 2025
  7. FLAUS A, Levigoureux E, Haesebaert J, Briet C, et al
    Prospective Multicenter Evaluation of [(11)C]Methionine PET/MRI Sensitivity Compared with MRI for Localizing Small Pituitary Neuroendocrine Tumor or Pituitary Adenoma in Cushing Disease.
    J Nucl Med. 2025 Aug 21:jnumed.124.269392. doi: 10.2967/jnumed.124.269392.
    >> Share

  8. ALBERT NL, Tabouret E, Le Rhun E, Sahm F, et al
    [(177)Lu]Lu-DOTATATE for Recurrent Meningioma (LUMEN-1, EORTC-2334-BTG): Study Protocol for a Randomized Phase II Trial.
    J Nucl Med. 2025 Aug 7:jnumed.125.269633. doi: 10.2967/jnumed.125.269633.
    >> Share

    April 2025
  9. FRANCA VELO A, Giantini Larsen A, Humm JL, Zanzonico P, et al
    Determination of the Intralesional Distribution of Theranostic (124)I-Omburtamab Convection-Enhanced Delivery in Treatment of Diffuse Intrinsic Pontine Glioma.
    J Nucl Med. 2025 Apr 30:jnumed.124.267995. doi: 10.2967/jnumed.124.267995.
    >> Share

  10. BARRY N, Kendrick J, Rowshanfarzad P, Hassan GM, et al
    An External, Independent Validation of an O-(2-[(18)F]Fluoroethyl)-l-Tyrosine PET Automatic Segmentation Network on a Single-Center, Prospective Dataset of Patients with Glioblastoma.
    J Nucl Med. 2025 Apr 3:jnumed.124.268925. doi: 10.2967/jnumed.124.268925.
    >> Share

    March 2025
  11. IMBER BS, Yu KKH, Abida W, Pike LRG, et al
    Symptomatic Prostate-Specific Membrane Antigen PET-Positive Radionecrosis After Multimodality Brain Metastasis-Directed Treatment Including [(177)Lu]Lu-PSMA-617.
    J Nucl Med. 2025 Mar 6:jnumed.124.269175. doi: 10.2967/jnumed.124.269175.
    >> Share

    January 2025
  12. LANGEN KJ, Stoffels G, Filss CP, Kocher M, et al
    Borderline Findings in O-(2-[(18)F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice.
    J Nucl Med. 2025 Jan 16:jnumed.124.268768. doi: 10.2967/jnumed.124.268768.
    >> Share

    November 2024
  13. ERMIS E, Bachmann N, Lutz K, Pyka T, et al
    Meningioma Revisited: Should Whole-Body Staging with [(68)Ga]Ga-DOTATOC PET/CT of High-Grade Meningiomas Become Standard Practice?
    J Nucl Med. 2024 Nov 21:jnumed.124.267934. doi: 10.2967/jnumed.124.267934.
    >> Share

    October 2024
  14. AMEREIN A, Maurer C, Kircher M, Gable A, et al
    Intraarterial Administration of Peptide Receptor Radionuclide Therapy in Patients with Advanced Meningioma: Initial Safety and Efficacy.
    J Nucl Med. 2024 Oct 24:jnumed.124.268217. doi: 10.2967/jnumed.124.268217.
    >> Share

  15. ALBERT NL, Preusser M, Galldiks N, Ivanidze J, et al
    Theranostics for Meningioma on the Rise: New EANM/EANO/RANO/SNMMI Guidelines Pave the Way to Improved Patient Outcomes Using Radiolabeled Somatostatin Receptor Ligands.
    J Nucl Med. 2024 Oct 10:jnumed.124.268314. doi: 10.2967/jnumed.124.268314.
    >> Share

    August 2024
  16. PANDIT-TASKAR N, Zanzonico PB, Grkovski M, Donzelli M, et al
    Theranostic Intratumoral Convection-Enhanced Delivery of (124)I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.
    J Nucl Med. 2024 Aug 14:jnumed.123.266365. doi: 10.2967/jnumed.123.266365.
    >> Share

  17. SEVERI S, Grassi I, Bongiovanni A, Nicolini S, et al
    Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.
    J Nucl Med. 2024 Aug 14:jnumed.123.266956. doi: 10.2967/jnumed.123.266956.
    >> Share

    July 2024
  18. WICHMANN CW, Morgan KA, Cao Z, Osellame LD, et al
    Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of (225)Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.
    J Nucl Med. 2024 Jul 25:jnumed.123.266894. doi: 10.2967/jnumed.123.266894.
    >> Share

  19. OSTER C, Kessler L, Blau T, Keyvani K, et al
    The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, (68)Ga-FAPI-46 PET Data, and Survival Data.
    J Nucl Med. 2024 Jul 3:jnumed.123.267151. doi: 10.2967/jnumed.123.267151.
    >> Share

    April 2024
  20. ROSEN J, Werner JM, Ceccon GS, Rosen EK, et al
    MRI and (18)F-FET PET for Multimodal Treatment Monitoring in Patients with Brain Metastases: A Cost-Effectiveness Analysis.
    J Nucl Med. 2024 Apr 25:jnumed.123.266687. doi: 10.2967/jnumed.123.266687.
    >> Share

    March 2024
  21. PRUIS IJ, Verburg FA, Balvers RK, Harteveld AA, et al
    [(18)F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.
    J Nucl Med. 2024 Mar 21:jnumed.123.266853. doi: 10.2967/jnumed.123.266853.
    >> Share

    February 2024
  22. EIGLER C, McDougall L, Bauman A, Bernhardt P, et al
    Radiolabeled Somatostatin Receptor Antagonist Versus Agonist for Peptide Receptor Radionuclide Therapy in Patients with Therapy-Resistant Meningioma: PROMENADE Phase 0 Study.
    J Nucl Med. 2024 Feb 29:jnumed.123.266817. doi: 10.2967/jnumed.123.266817.
    >> Share

  23. LOHMANN P, Gutsche R, Werner JM, Shah NJ, et al
    Example of Artificial Intelligence-Based Decision Support for Amino Acid PET: Early Prediction of Suspected Brain Tumor Foci for Patient Management.
    J Nucl Med. 2024 Feb 15:jnumed.123.267112. doi: 10.2967/jnumed.123.267112.
    >> Share

  24. TOLBOOM N, Verger A, Albert NL, Fraioli F, et al
    Theranostics in Neurooncology: Heading Toward New Horizons.
    J Nucl Med. 2024;65:167-173.
    >> Share

    October 2023
  25. MAULER J, Lohmann P, Maudsley AA, Sheriff S, et al
    Diagnostic Accuracy of MR Spectroscopic Imaging and (18)F-FET PET for Identifying Glioma: A Biopsy-Controlled Hybrid PET/MRI Study.
    J Nucl Med. 2023 Oct 26:jnumed.123.265868. doi: 10.2967/jnumed.123.265868.
    >> Share

    September 2023
  26. HABERBOSCH L, Gillett D, MacFarlane J, Koulouri O, et al
    Dual Role for l-[Methyl-(11)C]-Methionine PET in Acromegaly: Confirming Remission and Detecting Recurrence.
    J Nucl Med. 2023 Sep 28:jnumed.123.266446. doi: 10.2967/jnumed.123.266446.
    >> Share

    August 2023
  27. LOHMEIER J, Radbruch H, Brenner W, Hamm B, et al
    Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteristics in Preoperative Glioma Using (18)F-FET PET.
    J Nucl Med. 2023 Aug 31:jnumed.123.265642. doi: 10.2967/jnumed.123.265642.
    >> Share

  28. VAN LITH SAM, Pruis IJ, Tolboom N, Snijders TJ, et al
    PET Imaging and Protein Expression of Prostate-Specific Membrane Antigen in Glioblastoma: A Multicenter Inventory Study.
    J Nucl Med. 2023 Aug 31:jnumed.123.265738. doi: 10.2967/jnumed.123.265738.
    >> Share

  29. GUTSCHE R, Lowis C, Ziemons K, Kocher M, et al
    Automated Brain Tumor Detection and Segmentation for Treatment Response Assessment Using Amino Acid PET.
    J Nucl Med. 2023 Aug 10:jnumed.123.265725. doi: 10.2967/jnumed.123.265725.
    >> Share

  30. ALBERT NL, Nelwan DV, Fleischmann DF, Quach S, et al
    Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma.
    J Nucl Med. 2023 Aug 3:jnumed.122.265247. doi: 10.2967/jnumed.122.265247.
    >> Share

    June 2023
  31. MILOSEVIC A, Styczen H, Grueneisen J, Li Y, et al
    Evaluation of [(68)Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
    J Nucl Med. 2023 Jun 29:jnumed.123.265424. doi: 10.2967/jnumed.123.265424.
    >> Share

    May 2023
  32. GALLDIKS N, Langen KJ
    Hybrid (18)F-FET PET and Perfusion MRI to Differentiate Disease Progression from Treatment-Related Changes in Malignant Brain Tumors.
    J Nucl Med. 2023 May 18:265647. doi: 10.2967/jnumed.123.265647.
    >> Share

    April 2023
  33. GRAEF J, Bluemel S, Brenner W, Amthauer H, et al
    [(177)Lu]Lu-PSMA Therapy as an Individual Treatment Approach for Patients with High-Grade Glioma: Dosimetry Results and Critical Statement.
    J Nucl Med. 2023 Apr 28:jnumed.122.264850. doi: 10.2967/jnumed.122.264850.
    >> Share

  34. SMITH NJ, Deaton TK, Territo W, Graner B, et al
    Hybrid (18)F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases.
    J Nucl Med. 2023 Apr 28:jnumed.122.265149. doi: 10.2967/jnumed.122.265149.
    >> Share

  35. GALLDIKS N, Lohmann P, Fink GR, Langen KJ, et al
    Amino Acid PET in Neurooncology.
    J Nucl Med. 2023 Apr 13:264859. doi: 10.2967/jnumed.122.264859.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016